Cargando…
Gene Editing for the Efficient Correction of a Recurrent COL7A1 Mutation in Recessive Dystrophic Epidermolysis Bullosa Keratinocytes
Clonal gene therapy protocols based on the precise manipulation of epidermal stem cells require highly efficient gene-editing molecular tools. We have combined adeno-associated virus (AAV)-mediated delivery of donor template DNA with transcription activator-like nucleases (TALE) expressed by adenovi...
Autores principales: | Chamorro, Cristina, Mencía, Angeles, Almarza, David, Duarte, Blanca, Büning, Hildegard, Sallach, Jessica, Hausser, Ingrid, Del Río, Marcela, Larcher, Fernando, Murillas, Rodolfo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014520/ https://www.ncbi.nlm.nih.gov/pubmed/27045209 http://dx.doi.org/10.1038/mtna.2016.19 |
Ejemplares similares
-
Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing
por: Bonafont, Jose, et al.
Publicado: (2021) -
Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual sgRNA CRISPR/Cas9-Mediated Gene Editing
por: Bonafont, Jose, et al.
Publicado: (2019) -
COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa
por: Hainzl, Stefan, et al.
Publicado: (2017) -
An RNA-targeted therapy for dystrophic epidermolysis bullosa
por: Peking, Patricia, et al.
Publicado: (2017) -
Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by in vivo CRISPR-Cas9 delivery using adenoviral vectors
por: García, Marta, et al.
Publicado: (2022)